Milton C. Ault III - 23 Dec 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Reporting relationship: Director
Issuer ticker: ALZN
Reported as of: 23 Dec 2025
Net transaction value: -$3,825
SEC form: 4
Accepted by SEC: 30 Dec 2025, 17:54:03 UTC
Prior SEC filing: 23 Dec 2025
Next SEC filing: 02 Jan 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Milton C. Ault, III, Chief Executive Officer of Ault & Company, Inc.

Key filing fact

Milton C. Ault III filed Form 4 for Alzamend Neuro, Inc. (ALZN) on 30 Dec 2025.

Key facts

This page summarizes Milton C. Ault III's Form 4 filing for Alzamend Neuro, Inc. (ALZN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Dec 2025, 17:54.

Change

Previous filing in this sequence was filed on 23 Dec 2025.
Current net transaction value: -$3,825.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001212502 Primary reporting owner

AULT MILTON C III

Relationship: Director
Address: 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS
Signature: By: /s/ Milton C. Ault, III, Chief Executive Officer of Ault & Company, Inc.
Signature date: 30 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALZN transaction

Common Stock

Sale

Transaction value: $3,825
Shares: -1,851
Change %: -100%
Price: $2.07
Shares after: 0
Date: 23 Dec 2025
Ownership: Direct
Footnotes: F1

ALZN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,260
Date: 23 Dec 2025
Ownership: By Ault Lending, LLC
Footnotes: F2

ALZN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,068
Date: 23 Dec 2025
Ownership: By Ault Life Sciences, Inc.
Footnotes: F3

ALZN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 61
Date: 23 Dec 2025
Ownership: By Ault Life Sciences Fund, LLC
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Such shares were sold at the direction of the reporting person, for purposes of realizing tax losses.

Footnote F2

Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.

Footnote F3

Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.

Footnote F4

Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.